Hadassah

Diabetes: An Ongoing Struggle

Tuesday, Jun 18 2019

Prof. Gil Leibowitz, head of the Diabetes Unit at the Hadassah Medical Organization’s Endocrinology and Metabolism Service, remembers himself as a scared, skinny seven-year-old when the doctor told his parents that he had type 1 diabetes. The year was 1969 and they were living in Beersheba. The city was a sleepy town, with a single hotel that had a swimming pool and a hospital that had been started by Hadassah the year following Israel’s Independence.

 “I took it hard,” Prof. Leibowitz says. “I remember the two words the doctor kept saying, izun and ishpuz '[balance and hospitalization]. And, of course, I also didn't understand the significance of childhood diabetes.”

Balance would be a challenge. Before 1969, there was no way for individuals with diabetes to test their blood sugar levels. The first meters weighed three pounds, cost $650, and were only available for physicians to use. Today, Prof. Leibowitz wears a tiny glucose-level monitor on his arm.

“I wanted to be like all the other kids, and I went on all the class field trips and played basketball,” he recalls. But when all his friends went to serve in the Israel Defense Forces, he was rejected. “Today, in a more sophisticated Israel, teens with diabetes can find a place in the army,” Prof. Leibowitz explains.

Prof. Leibowitz turned his disappointment into a lifelong ambition to treat and help cure diabetes. Many advances have occurred over the last half-century since he was diagnosed, and Hadassah has played a historic role in helping to prevent diabetes and to improve the lives of those suffering from this chronic disease. 

Six percent of Israelis aged 20-79 have either type 1 or type 2 diabetes. The number rises to 20 percent among the elderly and 50 percent among Jerusalem's Arab women. Certain populations, such as Yemenite Jews and Ethiopian Jews, used to have very low rates of diabetes until they came to Israel and adopted a western-style diet. In the United States, the diabetes rates are as high as 10 percent overall.

Prof. Leibowitz’ own research at Hadassah has focused on the critical role of beta cells in the development of diabetes. Hadassah is also a major resource for clinical trials of medications outside the United States. Ongoing collaborations include those with the University of Helsinki and the Joslin Diabetes Center in Boston.

Learn more about the Hadassah Medical Organization.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Thursday, Jul 11 2019

Hadassah Doctors Give a Gazan Patient With an Incurable Skin Disease a “Normal Life”

Pioneering treatment by physicians at Hadassah Hospital Ein Kerem is giving a Gazan man who suffers from...

READ MORE ›
alt_text

Thursday, Jul 11 2019

Breakthrough at Hadassah Hospital in Correcting Scoliosis for Special-Needs Teen

Spine specialists at Hadassah Hospital Ein Kerem used an innovative, minimally invasive approach to correct scoliosis in a 14-year-old with Down syndrome.

READ MORE ›
alt_text

Tuesday, Jul 2 2019

Hadassah Researchers Adapt a Text-Messaging Program to Help IDF Soldiers Kick the Tobacco Habit

Researchers from Hadassah, the Hebrew University, the Israel Defense Forces Medical Corps, and the Israel Cancer Association have shown for the first time that a text-based cessation program can help soldiers stop smoking.

READ MORE ›
alt_text

Tuesday, Jul 2 2019

“Just Clownin’ Around!” Medical Clown at Hadassah Hospital Turns Tears Into Laughter

Clowns aren't just at circuses anymore! At Hadassah Hospital in Jerusalem, clowns, working as part of the medical team, bring smiles to the faces of sick patients—children and adults alike—every day.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More